Thanks for your interest in Transpharmation Ltd. We'd like to keep you updated on what's new and relevant. Please sign up to receive our newsletters, we won't bombard you or share your details with any other party and you can unsubscribe at any time.
Company of the year - you're in safe hands
Company of the year!
Pharma Tech Outlook magazine have named Transpharmation ‘company of the year’ in their ‘top 5 UK CRO’s’ feature. We’re proud of this achievement on behalf of all the clients that we’ve worked with over the years and it’s a great start to our 10th anniversary year. In his interview, our CEO, Mark Duxon, describes how Transpharmation differentiates itself from competitors and what his aspirations are for the company into 2020 and beyond.
Imperial College London is ranked 9th in the Times Higher Education World University Rankings (2019) and so it seems fitting that Transpharmation have secured a new facility here to carry out specialist Category 3 work for one of our European clients. Steeped in history, this is a centre of excellence that will inspire our scientists to deliver their best work, and also demonstrates our ongoing commitment to adapt to our client's changing needs.
Expanding the team
We’re continuing to grow the Transpharmation team of experts to meet global demand for our services and deliver leading results for our clients. Our recruitment process finds outstanding scientists with relevant expertise who are keen to push boundaries, and are motivated by what we do and the service we provide. Five such scientists have joined our ranks in recent months, across the UK and Ireland sites.
We’re always keen to hear from you
Transpharmation Ltd are a global CRO, wherever you are, whatever language you speak, we’d be happy to work with you. If you have a project in mind for 2020, please contact me, Kerry Waters, Business Development Manager
You are receiving this newsletter because you have expressed an interest in Transpharmation in the past. If you no longer wish to receive communications such as this from us please unsubscribe here Unsubscribe Thank you.